Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide

Author： Cuperlovic-Culf Miroslava Touaibia Mohamed St-Coeur Patrick-Denis Poitras Julie Morin Pier Jr Culf Adrian S.

Publisher： MDPI

E-ISSN： 2218-1989|4|3|807-830

ISSN： 2218-1989

Source： Metabolites, Vol.4, Iss.3, 2014-09, pp. : 807-830

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Thoroughly Validated Virtual Screening Strategy for Discovery of Novel HDAC3 Inhibitors

By Hu Huabin Xia Jie Wang Dongmei Wang Xiang Simon Wu Song

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 137-137

MDPI

Access to resources Recommend Favorite

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors

By Thomas Elizabeth A.

Pharmaceuticals, Vol. 7, Iss. 6, 2014-05 ,pp. : 634-661

MDPI

Access to resources Recommend Favorite

CIK Cells and HDAC Inhibitors in Multiple Myeloma

By Stephan David Weiher Hans Schmidt-Wolf Ingo G.H.

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 945-945

MDPI

Access to resources Recommend Favorite

HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells

By Chen Yun Tsai Ya-Hui Tseng Sheng-Hong

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 258-258

MDPI

Access to resources Recommend Favorite

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo

By Li Wei Wang Jie Jiang Hong-Ru Xu Xiao-Li Zhang Jun Liu Mei-Lin Zhai Ling-Yun

International Journal of Molecular Sciences, Vol. 12, Iss. 1, 2011-01 ,pp. : 668-681

MDPI

Access to resources Recommend Favorite